Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIODARONE vs AMIVANTAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMIODARONE vs AMIVANTAMAB: Safety Overview

Metric AMIODARONE AMIVANTAMAB
Total FAERS Reports 25,143 748
Deaths Reported 3,845 116
Death Rate 15.3% 15.5%
Hospitalizations 13,711 445
Average Patient Age 69.9 yrs 63.5 yrs
% Female Patients 36.9% 65.3%
FDA Approval Date Apr 12, 2005 N/A
Manufacturer Aurobindo Pharma Limited Janssen Biotech, Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued N/A